| Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine LR Baden, HM El Sahly, B Essink, K Kotloff, S Frey, R Novak, D Diemert, ... New England journal of medicine 384 (5), 403-416, 2021 | 10204 | 2021 |
| An mRNA vaccine against SARS-CoV-2—preliminary report LA Jackson, EJ Anderson, NG Rouphael, PC Roberts, M Makhene, ... New England journal of medicine 383 (20), 1920-1931, 2020 | 3517 | 2020 |
| Antibody resistance of SARS-CoV-2 variants B. 1.351 and B. 1.1. 7 P Wang, MS Nair, L Liu, S Iketani, Y Luo, Y Guo, M Wang, J Yu, B Zhang, ... Nature 593 (7857), 130-135, 2021 | 2271 | 2021 |
| Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1 X Wu, ZY Yang, Y Li, CM Hogerkorp, WR Schief, MS Seaman, T Zhou, ... Science 329 (5993), 856-861, 2010 | 2033 | 2010 |
| Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies JR Mascola, G Stiegler, TC VanCott, H Katinger, CB Carpenter, ... Nature medicine 6 (2), 207-210, 2000 | 1622 | 2000 |
| SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness KS Corbett, DK Edwards, SR Leist, OM Abiona, S Boyoglu-Barnum, ... Nature 586 (7830), 567-571, 2020 | 1474 | 2020 |
| Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01 T Zhou, I Georgiev, X Wu, ZY Yang, K Dai, A Finzi, Y Do Kwon, JF Scheid, ... Science 329 (5993), 811-817, 2010 | 1343 | 2010 |
| Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing … M Li, F Gao, JR Mascola, L Stamatatos, VR Polonis, M Koutsoukos, ... Journal of virology 79 (16), 10108-10125, 2005 | 1271 | 2005 |
| Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates KS Corbett, B Flynn, KE Foulds, JR Francica, S Boyoglu-Barnum, ... New England Journal of Medicine 383 (16), 1544-1555, 2020 | 1164 | 2020 |
| Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus HX Liao, R Lynch, T Zhou, F Gao, SM Alam, SD Boyd, AZ Fire, KM Roskin, ... Nature 496 (7446), 469-476, 2013 | 1141 | 2013 |
| Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals JF Scheid, H Mouquet, N Feldhahn, MS Seaman, K Velinzon, J Pietzsch, ... Nature 458 (7238), 636-640, 2009 | 1067 | 2009 |
| Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 JS McLellan, M Pancera, C Carrico, J Gorman, JP Julien, R Khayat, ... Nature 480 (7377), 336-343, 2011 | 1038 | 2011 |
| Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6 PD by passive transfer of neutralizing antibodies JR Mascola, MG Lewis, G Stiegler, D Harris, TC VanCott, D Hayes, ... Journal of virology 73 (5), 4009-4018, 1999 | 1016 | 1999 |
| Broad and potent neutralization of HIV-1 by a gp41-specific human antibody J Huang, G Ofek, L Laub, MK Louder, NA Doria-Rose, NS Longo, ... Nature 491 (7424), 406-412, 2012 | 981 | 2012 |
| Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing X Wu, T Zhou, J Zhu, B Zhang, I Georgiev, C Wang, X Chen, NS Longo, ... Science 333 (6049), 1593-1602, 2011 | 969 | 2011 |
| Human skin Langerhans cells are targets of dengue virus infection SJL Wu, G Grouard-Vogel, W Sun, JR Mascola, E Brachtel, R Putvatana, ... Nature medicine 6 (7), 816-820, 2000 | 913 | 2000 |
| Structure and immune recognition of trimeric pre-fusion HIV-1 Env M Pancera, T Zhou, A Druz, IS Georgiev, C Soto, J Gorman, J Huang, ... Nature 514 (7523), 455-461, 2014 | 832 | 2014 |
| Durability of responses after SARS-CoV-2 mRNA-1273 vaccination AT Widge, NG Rouphael, LA Jackson, EJ Anderson, PC Roberts, ... New England Journal of Medicine 384 (1), 80-82, 2021 | 821 | 2021 |
| Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies NA Doria-Rose, CA Schramm, J Gorman, PL Moore, JN Bhiman, ... Nature 509 (7498), 55-62, 2014 | 788 | 2014 |
| Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies MS Seaman, H Janes, N Hawkins, LE Grandpre, C Devoy, A Giri, ... Journal of virology 84 (3), 1439-1452, 2010 | 725 | 2010 |
